Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study

被引：0
作者：
Kheirollahi, Asma [1 ]
Hamidi, Hediyeh [1 ]
Vatannejad, Akram [1 ]
机构：
[1] Univ Tehran, Fac Vet Med, Dept Comparat Biosci, Tehran, Iran
来源：
BMC RESEARCH NOTES | 2025年 / 18卷 / 01期
关键词：
Polycystic ovary syndrome; PCOS phenotypes; Infertility; Recurrent pregnancy loss; MANAGEMENT; CRITERIA;
D O I：
10.1186/s13104-025-07202-6
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
ObjectivePolycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by diverse clinical and metabolic manifestations. This study aimed to investigate the prevalence of PCOS phenotypes and their association with hematological, biochemical, and hormonal parameters in PCOS, with a particular focus on infertile women and those with recurrent pregnancy loss (RPL).ResultsPhenotype A was the most prevalent phenotype overall and within both infertile and RPL subgroups. However, no significant differences in hematological, biochemical, or hormonal parameters were observed among the PCOS phenotypes, except for lower RBC and hematocrit levels in phenotype F. PCOS women with RPL demonstrate significantly lower levels of RBC, hemoglobin, and hematocrit in phenotype F.
引用
收藏
页数：7
相关论文
共 42 条
[1]  
[Абашова Елена Ивановна Abashova Elena I.], 2020, [Журнал акушерства и женских болезней, Journal of obstetrics and womans diseases], V69, P7, DOI 10.17816/JOWD6967-16
[2]   Peripheral hematological parameters in women with polycystic ovary syndrome [J].
ALhabardi, Nadiah A. ;
Al-Wutayd, Osama ;
Eltayieb, Khalid M. ;
Shiha, Yasir S. ;
AL-Shafei, Ahmad, I ;
Adam, Ishag .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (09)
[3]  
Ali IN., 2016, Eur J Biomedical, V3, P65
[4]   The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome [J].
Amiri, Mina ;
Bidhendi Yarandi, Razieh ;
Nahidi, Fatemeh ;
Tohidi, Maryam ;
Tehrani, Fahimeh Ramezani .
CLINICAL ENDOCRINOLOGY, 2019, 90 (01) :129-137
[5]   Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study [J].
Andrisani, Alessandra ;
Dona, Gabriella ;
Sabbadin, Chiara ;
Tibaldi, Elena ;
Dessole, Francesco ;
Travain, Valentina Bosello ;
Marin, Loris ;
Brunati, Anna Maria ;
Ambrosini, Guido ;
Armanini, Decio ;
Ragazzi, Eugenio ;
Bordin, Luciana .
GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (03) :233-237
[6]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[7]   Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype [J].
Bil, Enes ;
Dilbaz, Berna ;
Cirik, Derya Akdag ;
Ozelci, Runa ;
Ozkaya, Enis ;
Dilbaz, Serdar .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (07) :837-843
[8]   Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond [J].
Borzan, Valentin ;
Lerchbaum, Elisabeth ;
Missbrenner, Cornelia ;
Heijboer, Annemieke C. ;
Goschnik, Michaela ;
Trummer, Christian ;
Theiler-Schwetz, Verena ;
Haudum, Christoph ;
Gumpold, Roswitha ;
Schweighofer, Natascha ;
Obermayer-Pietsch, Barbara .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) :1-14
[9]   Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women [J].
Carmina, E ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1897-1899
[10]   Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups [J].
Chang, WY ;
Knochenhauer, ES ;
Bartolucci, AA ;
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (06) :1717-1723
12345